Crucially, whether these genes influence tumor development through established pathways—FcεRI signaling (MS4A2), Integrin-β1/FAK (IGSF10), or ERK transduction (MFAP3L)—requires further validation, as does their relationship with MSC activity. This evidence concerns the gene IGSF10 and neoplasm.